Cargando…

Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report

Hepatocellular carcinoma (HCC), combined with hepatic hydatid disease, is a rare clinical case, having certain specificity in clinical diagnosis and treatment. We report a case of HCC combined with hepatic hydatid disease treated in our clinic to arouse the attention of clinicians to the disease. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiwu, Ma, Chenzhe, Song, Xuewen, Tang, Futian, Guo, Lingyun, Mao, Jie, Li, Yumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847199/
https://www.ncbi.nlm.nih.gov/pubmed/35187050
http://dx.doi.org/10.3389/fsurg.2021.816501
_version_ 1784652000790577152
author Guo, Jiwu
Ma, Chenzhe
Song, Xuewen
Tang, Futian
Guo, Lingyun
Mao, Jie
Li, Yumin
author_facet Guo, Jiwu
Ma, Chenzhe
Song, Xuewen
Tang, Futian
Guo, Lingyun
Mao, Jie
Li, Yumin
author_sort Guo, Jiwu
collection PubMed
description Hepatocellular carcinoma (HCC), combined with hepatic hydatid disease, is a rare clinical case, having certain specificity in clinical diagnosis and treatment. We report a case of HCC combined with hepatic hydatid disease treated in our clinic to arouse the attention of clinicians to the disease. A 54-year-old female patient was admitted to the clinic on October 31, 2016 because of “Intermittent upper abdominal pain and discomfort for 1 month.” Abdominal CT in the previous hospital showed liver space-occupying lesions, and hepatic hydatid disease should be considered. The patient had a history of hepatitis B virus (HBV) infection since childhood but has not received antiviral treatment. She did have a history of life in pastoral areas. Laboratory examination results were as follows: alpha-fetoprotein (AFP) 1,210 ng/ml, HBV DNA: 5.32E + 3 IU/ml. Casoni test was positive. Enhanced CT of abdomen suggestion was: malignant liver tumor, hepatic hydatid disease. Gastroscopy and colonoscopy showed no abnormalities. She underwent an operation on November 10, 2016. Segment 5, 8 of hepatic, echinococcus internal capsule, and cholecyst were all removed. She took albendazole (0.4 g/day) for 6 months and oral entecavir (0.5 mg/day) antiviral treatment for a long time after surgery. From May 2017 to October 2019, a total of 5 cycles of transarterial chemotherapy embolization (TACE) were performed. The patient underwent surgical treatment, followed by TACE, antiviral therapy, and sequential albendazole treatment. The AFP level increased significantly, but there was no obvious recurrence of HCC in imaging.
format Online
Article
Text
id pubmed-8847199
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88471992022-02-17 Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report Guo, Jiwu Ma, Chenzhe Song, Xuewen Tang, Futian Guo, Lingyun Mao, Jie Li, Yumin Front Surg Surgery Hepatocellular carcinoma (HCC), combined with hepatic hydatid disease, is a rare clinical case, having certain specificity in clinical diagnosis and treatment. We report a case of HCC combined with hepatic hydatid disease treated in our clinic to arouse the attention of clinicians to the disease. A 54-year-old female patient was admitted to the clinic on October 31, 2016 because of “Intermittent upper abdominal pain and discomfort for 1 month.” Abdominal CT in the previous hospital showed liver space-occupying lesions, and hepatic hydatid disease should be considered. The patient had a history of hepatitis B virus (HBV) infection since childhood but has not received antiviral treatment. She did have a history of life in pastoral areas. Laboratory examination results were as follows: alpha-fetoprotein (AFP) 1,210 ng/ml, HBV DNA: 5.32E + 3 IU/ml. Casoni test was positive. Enhanced CT of abdomen suggestion was: malignant liver tumor, hepatic hydatid disease. Gastroscopy and colonoscopy showed no abnormalities. She underwent an operation on November 10, 2016. Segment 5, 8 of hepatic, echinococcus internal capsule, and cholecyst were all removed. She took albendazole (0.4 g/day) for 6 months and oral entecavir (0.5 mg/day) antiviral treatment for a long time after surgery. From May 2017 to October 2019, a total of 5 cycles of transarterial chemotherapy embolization (TACE) were performed. The patient underwent surgical treatment, followed by TACE, antiviral therapy, and sequential albendazole treatment. The AFP level increased significantly, but there was no obvious recurrence of HCC in imaging. Frontiers Media S.A. 2022-02-02 /pmc/articles/PMC8847199/ /pubmed/35187050 http://dx.doi.org/10.3389/fsurg.2021.816501 Text en Copyright © 2022 Guo, Ma, Song, Tang, Guo, Mao and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Guo, Jiwu
Ma, Chenzhe
Song, Xuewen
Tang, Futian
Guo, Lingyun
Mao, Jie
Li, Yumin
Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report
title Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report
title_full Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report
title_fullStr Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report
title_full_unstemmed Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report
title_short Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report
title_sort hepatocellular carcinoma complicated by echinococcal cyst: a case report
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847199/
https://www.ncbi.nlm.nih.gov/pubmed/35187050
http://dx.doi.org/10.3389/fsurg.2021.816501
work_keys_str_mv AT guojiwu hepatocellularcarcinomacomplicatedbyechinococcalcystacasereport
AT machenzhe hepatocellularcarcinomacomplicatedbyechinococcalcystacasereport
AT songxuewen hepatocellularcarcinomacomplicatedbyechinococcalcystacasereport
AT tangfutian hepatocellularcarcinomacomplicatedbyechinococcalcystacasereport
AT guolingyun hepatocellularcarcinomacomplicatedbyechinococcalcystacasereport
AT maojie hepatocellularcarcinomacomplicatedbyechinococcalcystacasereport
AT liyumin hepatocellularcarcinomacomplicatedbyechinococcalcystacasereport